NCT01110239

Brief Summary

In remote preconditioning, ischemia in one organ protects distant organs from ischemic insults. e.g. brief induced limb ischemia protects the brain from an otherwise more severe stroke. The objective of this study is to determine if remote ischemic preconditioning can be safely and effectively instituted in patients with subarachnoid hemorrhage, who are at high risk for developing disabling cerebral ischemia. The investigators will also preliminarily assess if there is evidence for neuroprotection. This will be a Phase 1b study. Additional objectives are:

  1. 1.to determine if remote ischemic preconditioning can be safely and effectively instituted in patients with subarachnoid hemorrhage, who are at high risk for developing disabling cerebral ischemia.
  2. 2.analogously to a dose-escalation study the investigators propose to study the safety and tolerability of increasing durations of limb ischemia until a target time of 10 minutes of limb ischemia has been reached.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2008

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 26, 2010

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

March 11, 2013

Completed
Last Updated

June 9, 2017

Status Verified

May 1, 2017

Enrollment Period

1.7 years

First QC Date

April 21, 2010

Results QC Date

August 9, 2011

Last Update Submit

May 5, 2017

Conditions

Keywords

limb preconditioningremote preconditioningischemic preconditioning

Outcome Measures

Primary Outcomes (2)

  • Number of Patients With Deep Vein Thrombosis for Safety Assessment.

    90 days

  • Visual Analog Scale Score as a Measure of Tolerability

    The visual analogue scale is a pain scale from 0-10, with 10 being maximum pain and is frequently used in research studies assessing patient discomfort.

    90 days

Study Arms (1)

remote limb preconditioning

EXPERIMENTAL

Subjects with subarachnoid hemorrhage will undergo escalating times of limb ischemia to determine tolerability and safety. The leg will be made transiently ischemic with application of a blood pressure cuff for up to 3 cycles of 10 minutes.

Procedure: remote limb preconditioning

Interventions

3 cycles of up to 10 minutes leg ischemia

Also known as: ischemic preconditioning
remote limb preconditioning

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Hunt Hess Scale \> 4
  • Inability to undergo limb preconditioning due to local wound or tissue breakdown, history of peripheral extremity vascular disease or patient discomfort.
  • Inability to obtain informed consent from the patient or a health care proxy.
  • Ankle-brachial index \< 0.7
  • Inability to start limb preconditioning within 4 days of bleeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Interventions

Ischemic Preconditioning

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Results Point of Contact

Title
Sebastian Koch
Organization
University Miami

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 21, 2010

First Posted

April 26, 2010

Study Start

November 1, 2008

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

June 9, 2017

Results First Posted

March 11, 2013

Record last verified: 2017-05